Deborah Ayeni

Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>

Giorgia Foggetti, Chuan Li, Hongchen Cai et al. · Cancer Discovery · 2021 · 122 citations · Full text

Medicine, Molecular Genetics, Oncology +17

The Next Wave of EGFR Tyrosine Kinase Inhibitors Enter the Clinic

Katerina Politi, Deborah Ayeni, Thomas J. Lynch · Cancer Cell · 2015 · 73 citations · Full text

Medicine, Oncology, Pharmacology +13

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance <i>EGFR</i> Mutations

Jacqueline H. Starrett, Alexis Guernet, Maria Emanuela Cuomo et al. · Cancer Research · 2020 · 60 citations · Full text

Medicine, Oncology, Pharmacology +16

Afatinib plus Cetuximab Delays Resistance Compared to Single-Agent Erlotinib or Afatinib in Mouse Models of TKI-Naïve EGFR L858R-Induced Lung Adenocarcinoma

Valentina Pirazzoli, Deborah Ayeni, Catherine B. Meador et al. · Clinical Cancer Research · 2015 · 49 citations

Medicine, Oncology, Pharmacology +16

EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth

Alexandra Kuhlmann-Hogan, Thekla Cordes, Ziyan Xu et al. · Cancer Discovery · 2024 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17